Two‐point‐NGS analysis of cancer genes in cell‐free DNA of metastatic cancer patients-Reference-Cited by-同舟云学术

Two‐point‐NGS analysis of cancer genes in cell‐free DNA of metastatic cancer patients

Published:2020-01-28 Issue:6 Volume:9 Page:2052-2061
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Palmieri Maria¹,Baldassarri Margherita²,Fava Francesca¹²,Fabbiani Alessandra¹²,Gelli Elisa¹,Tita Rossella²,Torre Pamela³,Petrioli Roberto³,Hadijstilianou Theodora⁴,Galimberti Daniela⁴,Cinotti Elisa⁵,Bengala Carmelo⁶,Mandalà Marco⁷,Piu Pietro⁸,Miano Salvatora Tindara³,Martellucci Ignazio³,Vannini Agnese³,Pinto Anna Maria²,Mencarelli Maria Antonietta²,Marsili Stefania³,Renieri Alessandra¹²^ORCID,Frullanti Elisa¹

Affiliation:

1. Medical Genetics University of Siena Siena Italy

2. Genetica Medica Azienda Ospedaliera Universitaria Senese Siena Italy

3. Oncology Azienda Ospedaliera Universitaria Senese Siena Italy

4. Department of Ophthalmology Referral Center for RetinoblastomaAzienda Ospedaliera Universitaria Senese Siena Italy

5. Department of Medical, Surgical and Neurosciences Dermatology Unit University of Siena Siena Italy

6. Medical Oncology Ospedale MisericordiaAzienda Toscana Sud‐Est Grosseto Italy

7. Department of Otology and Skull Base Surgery University of Siena Siena Italy

8. VisMederi s.r.l Strada del Petriccio e Belriguardo Siena Italy

Funder

Istituto Toscano Tumori

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2782

Reference22 articles.

1. Clinical utilization pattern of Liquid Biopsies (LB) to detect actionable driver mutations, guide treatment decisions and monitor disease burden during treatment of 33 metastatic colorectal cancer (mCRC) patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic;Ghatalia P;Front Oncol,2019

2. Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure

3. Clonal evolution of myelofibrosis treated with hematopoietic transplantation, using RUXOLITINIB for chronic GvHD: A case report

4. Low‐level TP 53 mutational load antecedes clonal expansion in chronic lymphocytic leukaemia

5. Subclones dominate at MDS progression following allogeneic hematopoietic cell transplant. JCI;Jacoby MA;Insight,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Circulating Tumor DNA as a Liquid Biomarker in Uveal Melanoma;Investigative Opthalmology & Visual Science;2024-02-06

2. Genetic Causes of Vascular Malformations and Common Signaling Pathways Involved in Their Formation;Dermatologic Clinics;2022-10

3. Liquid biopsy in Retinoblastoma: A review;Seminars in Ophthalmology;2022-05-23

4. Leveraging the Fragment Length of Circulating Tumour DNA to Improve Molecular Profiling of Solid Tumour Malignancies with Next-Generation Sequencing: A Pathway to Advanced Non-invasive Diagnostics in Precision Oncology?;Molecular Diagnosis & Therapy;2021-05-20

5. MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy;Journal of Vascular Surgery: Venous and Lymphatic Disorders;2021-05